By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

Explore LENN nanoparticles, a groundbreaking technology for delivering mRNA therapies to bladder cancer cells with enhanced ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

For the first time ever in a human, doctors have performed coronary artery bypass grafting without having to cut through the patient’s chest, similar to how many aortic valve replacement procedures ...

For the first time ever in a human, doctors have performed coronary artery bypass grafting without having to cut through the ...

Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple ...

Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...

Eleven patients with refractory autoimmune hemolytic anemia (AIHA) were all brought into drug-free remission with CAR T-cell ...

Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 ...

Exosome-associated THSD7A is identified as a key trigger of filopodia formation in cancer cells and neurons, revealing a ...